These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 34788739)
21. Contrasting Distribution of SARS-CoV-2 Lineages across Multiple Rounds of Pandemic Waves in West Bengal, the Gateway of East and North-East States of India. Singh AK; Laskar R; Banerjee A; Mondal RK; Gupta B; Deb S; Dutta S; Patra S; Ghosh T; Sarkar S; Ghosh S; Bhattacharya S; Roy D; Chakraborty A; Chowdhury M; Mahaptra S; Paul A; Mazumder A; Chowdhury A; Chatterjee SS; Sarkar A; Ray R; Pal K; Jana A; Barik G; Ganguly S; Chatterjee M; Majhi D; Bandopadhyay B; Das S; Maitra A; Biswas NK Microbiol Spectr; 2022 Aug; 10(4):e0091422. PubMed ID: 35852336 [TBL] [Abstract][Full Text] [Related]
22. Genomic Analysis and Tracking of SARS-CoV-2 Variants in Gwangju, South Korea, From 2020 to 2022. Lee YU; Lee K; Lee H; Park JW; Cho SJ; Park JS; Mun J; Park S; Lee CM; Lee J; Seo J; Kim Y; Kim SH; Chung YS Influenza Other Respir Viruses; 2024 Jun; 18(6):e13350. PubMed ID: 38923353 [TBL] [Abstract][Full Text] [Related]
23. Genomic reconstruction of the SARS-CoV-2 epidemic in England. Vöhringer HS; Sanderson T; Sinnott M; De Maio N; Nguyen T; Goater R; Schwach F; Harrison I; Hellewell J; Ariani CV; Gonçalves S; Jackson DK; Johnston I; Jung AW; Saint C; Sillitoe J; Suciu M; Goldman N; Panovska-Griffiths J; ; ; Birney E; Volz E; Funk S; Kwiatkowski D; Chand M; Martincorena I; Barrett JC; Gerstung M Nature; 2021 Dec; 600(7889):506-511. PubMed ID: 34649268 [TBL] [Abstract][Full Text] [Related]
24. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India. Singh P; Sharma K; Singh P; Bhargava A; Negi SS; Sharma P; Bhise M; Tripathi MK; Jindal A; Nagarkar NM Microb Pathog; 2022 Mar; 164():105404. PubMed ID: 35065253 [TBL] [Abstract][Full Text] [Related]
25. Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India. Hudson B S; Kolte V; Khan A; Sharma G J Med Virol; 2021 Apr; 93(4):2534-2537. PubMed ID: 33368386 [TBL] [Abstract][Full Text] [Related]
26. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
27. Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India. Sharma S; Dash PK; Sharma SK; Srivastava A; Kumar JS; Karothia BS; Chelvam KT; Singh S; Gupta A; Yadav RG; Yadav R; Greeshma TS; Kushwaha PK; Kumar RB; Nagar DP; Nandan M; Kumar S; Thavaselvam D; Dubey DK Sci Rep; 2021 Sep; 11(1):18126. PubMed ID: 34518554 [TBL] [Abstract][Full Text] [Related]
28. Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil. Wink PL; Ramalho R; Monteiro FL; Volpato FCZ; Willig JB; Lovison OVA; Zavascki AP; Barth AL; Martins AF Microbiol Spectr; 2022 Feb; 10(1):e0151121. PubMed ID: 35171035 [TBL] [Abstract][Full Text] [Related]
29. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Yadav PD; Nyayanit DA; Majumdar T; Patil S; Kaur H; Gupta N; Shete AM; Pandit P; Kumar A; Aggarwal N; Narayan J; Vijay N; Kalawat U; Sugunan AP; Munivenkatappa A; Sharma T; Devi S; Majumdar T; Jaryal S; Bakshi R; Joshi Y; Sahay R; Shastri J; Singh M; Kumar M; Rawat V; Dutta S; Yadav S; Krishnasamy K; Raut S; Biswas D; Borkakoty B; Verma S; Rani S; Deval H; Patel D; Turuk J; Malhotra B; Fomda B; Nag V; Jain A; Bhargava A; Potdar V; Cherian S; Abraham P; Gopal A; Panda S; Bhargava B Viruses; 2021 May; 13(5):. PubMed ID: 34067745 [TBL] [Abstract][Full Text] [Related]
30. Circulation and Evolution of SARS-CoV-2 in India: Let the Data Speak. Limaye S; Kasibhatla SM; Ramtirthkar M; Kinikar M; Kale MM; Kulkarni-Kale U Viruses; 2021 Nov; 13(11):. PubMed ID: 34835044 [TBL] [Abstract][Full Text] [Related]
31. Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh. Al Nahid A; Ghosh A Infect Genet Evol; 2021 Nov; 95():105057. PubMed ID: 34481060 [TBL] [Abstract][Full Text] [Related]
32. COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years. Khairnar K; Tomar SS Virus Res; 2024 Jun; 344():199365. PubMed ID: 38527669 [TBL] [Abstract][Full Text] [Related]
33. Epidemiological and Genetic Characteristics of Respiratory Viral Coinfections with Different Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Trifonova I; Korsun N; Madzharova I; Alexiev I; Ivanov I; Levterova V; Grigorova L; Stoikov I; Donchev D; Christova I Viruses; 2024 Jun; 16(6):. PubMed ID: 38932250 [TBL] [Abstract][Full Text] [Related]
34. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins. Sahin E; Bozdayi G; Yigit S; Muftah H; Dizbay M; Tunccan OG; Fidan I; Caglar K J Med Virol; 2021 Oct; 93(10):6016-6026. PubMed ID: 34241906 [TBL] [Abstract][Full Text] [Related]
35. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review. Tabibzadeh A; Esghaei M; Soltani S; Yousefi P; Taherizadeh M; Safarnezhad Tameshkel F; Golahdooz M; Panahi M; Ajdarkosh H; Zamani F; Karbalaie Niya MH Vet Med Sci; 2021 Mar; 7(2):559-571. PubMed ID: 33210477 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations. Sarkar R; Mitra S; Chandra P; Saha P; Banerjee A; Dutta S; Chawla-Sarkar M Arch Virol; 2021 Mar; 166(3):801-812. PubMed ID: 33464421 [TBL] [Abstract][Full Text] [Related]
37. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread. Bui NN; Lin YT; Huang SH; Lin CW Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Rotondo JC; Martini F; Maritati M; Mazziotta C; Di Mauro G; Lanzillotti C; Barp N; Gallerani A; Tognon M; Contini C Viruses; 2021 Aug; 13(9):. PubMed ID: 34578269 [TBL] [Abstract][Full Text] [Related]
39. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2. Li G; Zhang L; Xue P Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776 [TBL] [Abstract][Full Text] [Related]
40. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients. Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]